Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Pangea Natural Food, Inc. ( (TSE:PNGA) ) just unveiled an announcement.
Pangea Wellness Inc. is rebranding as The Precision Peptide Company Inc., reflecting its focus on clean-label foods and advanced wellness solutions, including needle-free peptide therapies offered through its Amino Innovations subsidiary. The North American firm specializes in products that support recovery, cognitive performance, and general health.
The company confirmed that its name change will take effect on March 18, 2026, when its common shares will begin trading on the CSE under the new symbol BPC, with updated CUSIP and ISIN identifiers but unchanged share capital. The move signals a strategic emphasis on precision peptide technologies while maintaining continuity for shareholders, as the capital structure remains intact despite the branding and ticker transition.
The most recent analyst rating on (TSE:PNGA) stock is a Hold with a C$0.35 price target. To see the full list of analyst forecasts on Pangea Natural Food, Inc. stock, see the TSE:PNGA Stock Forecast page.
Spark’s Take on TSE:PNGA Stock
According to Spark, TipRanks’ AI Analyst, TSE:PNGA is a Neutral.
The score is held down primarily by weak financial performance—persistent losses and accelerating cash burn—despite low leverage. Technicals are supportive with strong momentum above major moving averages, but overbought indicators temper the upside. Valuation remains constrained by negative earnings and no dividend support.
To see Spark’s full report on TSE:PNGA stock, click here.
More about Pangea Natural Food, Inc.
Pangea Wellness Inc., soon to be renamed The Precision Peptide Company Inc., is a North American manufacturer focused on clean-label foods and innovative wellness products. Through its subsidiary Amino Innovations, it develops advanced, needle-free peptide therapies aimed at supporting recovery, cognitive function, and overall health.
Average Trading Volume: 132,202
Technical Sentiment Signal: Buy
Current Market Cap: C$10.55M
Learn more about PNGA stock on TipRanks’ Stock Analysis page.